Stocktoria
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.0B | $4.0B | $4.1B | $4.0B | $3.5B | $2.9B | $2.6B | $2.3B | $1.9B | $1.7B |
| SG&A expense | $743.1M | $751.0M | $747.9M | $665.1M | $619.9M | $528.9M | $517.6M | $443.9M | $371.3M | $364.7M |
| Operating income | $25.2M | $227.3M | $617.3M | $651.0M | $589.9M | $432.7M | $351.2M | $331.4M | $288.3M | $237.6M |
| Interest expense | — | — | $136.7M | $59.3M | $73.9M | $86.4M | $60.9M | $63.8M | $29.8M | $27.7M |
| Income tax | $42.7M | $67.8M | $100.9M | $130.4M | $81.9M | $81.8M | $50.0M | $54.5M | $171.4M | $66.8M |
| Net income | -$144.3M | $22.2M | $474.6M | $486.2M | $391.0M | $364.3M | $252.0M | $226.4M | $123.4M | $154.8M |
| EPS (diluted) | $-2.91 | $0.20 | $9.22 | $9.48 | $7.60 | $7.20 | $5.07 | $4.62 | $2.54 | $3.23 |
| Operating cash flow | $737.6M | $734.6M | $683.9M | $619.6M | $760.8M | $546.6M | $480.9M | $441.1M | $318.1M | $316.9M |
| Cash & equivalents | $213.8M | $194.6M | $276.8M | $233.9M | $241.2M | $228.4M | $238.0M | $195.4M | $163.8M | $117.6M |
| Inventory | $299.1M | $278.5M | $380.3M | $255.8M | $199.1M | $185.7M | $160.7M | $127.9M | $115.0M | $95.8M |
| Total assets | $7.1B | $7.5B | $8.2B | $7.6B | $7.0B | $5.5B | $4.7B | $3.9B | $2.9B | $2.7B |
| Total liabilities | $3.9B | $4.0B | $4.5B | $4.6B | $4.4B | $3.3B | $3.0B | $2.5B | $1.9B | $1.9B |
| Shareholders' equity | $3.2B | $3.5B | $3.6B | $3.0B | $2.5B | $2.1B | $1.6B | $1.3B | $1.0B | $839.1M |
Growth · year-over-year · Revenue CAGR 10.2%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | -0.9% | -1.9% | +3.9% | +12.3% | +21.1% | +11.5% | +15.7% | +22.0% | +10.5% | +23.3% |
| Net income growth | -750.1% | -95.3% | -2.4% | +24.4% | +7.3% | +44.6% | +11.3% | +83.5% | -20.3% | +3.7% |
| EPS growth | -1555.0% | -97.8% | -2.7% | +24.7% | +5.6% | +42.0% | +9.7% | +81.9% | -21.4% | +3.2% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-27. Facts plus Stocktoria's own computed scores — not investment advice.